Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for misrepresentations regarding its accounts receivable during the Class Period from July 18, 2024, to November 12, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Ardent Health made false statements about its accounts receivable management, including the methods used to determine collectability and the adequacy of its professional malpractice liability insurance [5]. - Defendants allegedly misrepresented that Ardent Health employed an active monitoring process for accounts receivable, which was not the case, as they utilized a 180-day cliff for reserving accounts [5]. - The lawsuit asserts that when issues regarding increased claim denials by third-party payors arose, Ardent Health downplayed the situation and failed to write off uncollectible accounts [5]. Group 2: Investor Information - Investors who purchased Ardent Health securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, investors can visit the provided link or contact the law firm for more information [3][6]. - A lead plaintiff must be appointed by March 9, 2026, to represent the interests of other class members in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [4]. - The firm has recovered hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone [4].

Representative Jonathan L. Jackson (D-Illinois) recently bought shares of Tenet Healthcare Corporation (NYSE:THC). In a filing disclosed on January 08th, the Representative disclosed that they had bought between $15,001 and $50,000 in Tenet Healthcare stock on December 10th. The trade occurred in the Representative’s “MORGAN STANLEY TRUST ACCOUNT” account. Get Tenet Healthcare alerts: Representative Jonathan L. Jackson also recently made the following trade(s): Sold $15,001 – $50,000 in shares of Robinhood ...

Crude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential.Subscribers get to use a 50+ stock model account, in-depth cash flow analyses of E&P firms, and live chat discussion of the sector.Sign up today for your two-week free trial and get a new lease on oil & gas! ...

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for allegedly misrepresenting its accounts receivable collection practices, leading to inflated financial results during the class period from July 18, 2024, to November 12, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Ardent stated it used an active monitoring process for accounts receivable collectability, but actually relied on a 180-day cliff method, which allowed for higher reported accounts receivable and delayed loss recognition [1] - Investors who suffered losses on Ardent investments have until March 9, 2026, to request lead plaintiff appointment [1] Group 2: Financial Impact - On November 12, 2025, Ardent announced a $43 million reduction in revenue due to changes in accounting estimates for accounts receivable collectability and a $54 million increase in professional liability reserves related to claims in New Mexico [2] - Following this announcement, Ardent's share price fell by $4.75, or approximately 33.8%, from $14.05 to $9.30 per share [2]

SAN FRANCISCO, Jan. 9, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Ardent Health, Inc. (NYSE: ARDT) following the company's Q3 2025 financial disclosures that revealed significant adverse accounting adjustments totaling about $90 million and sent the stock tumbling over 33% in mid-November. The lawsuit seeks to represent investors who purchased or otherwise acquired Ardent securities between July 18, 2024 and November 12, 2025. National shareholders rights firm Hagens Berma ...

Key Takeaways Global healthcare rebounded late in 2025 as U.S. drug pricing uncertainty eased, driving strong ETF inflows.Policy clarity, aging populations, and AI innovation are key drivers for healthcare growth in 2026.VHT, XLV and IXJ offer diversified exposure to healthcare's recovery while reducing single-stock risk.2025 was a tumultuous year for the global healthcare sector. For much of the year, policy uncertainty, particularly around U.S. drug pricing and trade barriers, weighed heavily on valuation ...

NEW YORK, Jan. 9, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health, inc." or the "Company") (NYSE: AGL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of agilon health, inc. investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 4, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/agilon ...

Valued at a market cap of $101.7 billion, McKesson Corporation (MCK) is a healthcare services and information technology company based in Irving, Texas. It primarily distributes pharmaceuticals, medical supplies, and healthcare products, while also offering advanced healthcare IT solutions, practice management services, and data analytics solutions. The company is ready to announce its fiscal Q3 earnings for 2026 after the market closes on Wednesday, Feb. 4. Before this event, analysts expect this health ...

Surgery Partners, Inc. (NASDAQ:SGRY) is one of the 12 Stocks that Will Bounce Back According to Wall Street Analysts. On December 19, RBC Capital reiterated its Buy rating on Surgery Partners, Inc. (NASDAQ:SGRY) with a price target of $31 on the stock. The research firm believes that the company’s long-term growth prospects are still intact. Earlier, on December 18, Mizuho Securities reduced its price target on Surgery Partners, Inc. (NASDAQ:SGRY) from $22 to $19 but kept its Outperform rating on the shar ...

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. concerning allegations of securities fraud and unlawful business practices by the company and its officers [2]. Financial Performance - On November 12, 2025, Ardent reported a $43 million decrease in third quarter 2025 revenue due to revised determinations of accounts receivable collectability after transitioning to a new revenue accounting system [3]. - The new accounting system, Kodiak RCA net revenue platform, allows for more precise determination of accounts receivable collectability and recognizes reserves earlier in an account's life cycle compared to the previous framework [3]. - Ardent also cut its 2025 EBITDA guidance by approximately 9.6%, from a range of $575 million - $625 million to $530 million - $555 million, citing persistent industry-wide cost pressures [3]. - Additionally, the company recorded a $54 million increase in professional liability reserves related to recent settlements and ongoing litigation, influenced by broader industry trends [3]. - Following these announcements, Ardent's stock price fell by $4.75 per share, or 33.81%, closing at $9.30 per share on November 13, 2025 [3].